Your AI governance policy document is not the problem. The problem is what the document thinks it is governing. Most health systems have arrived at the same answer to "do we have AI governance?": a policy document, a committee, and a checkmark in the IT compliance audit. That is not governance. That is governance theater.
I say this having sat in the rooms where these documents get written, approved, and then ignored the moment a vendor demo triggers an emergency board discussion about competitors who have already moved.
Real AI governance in a health system is not a document. It is a stack: five interconnected layers that most organizations build backward or skip entirely.
You cannot govern an AI tool you do not understand. You cannot understand a tool you cannot interrogate. And you cannot interrogate a tool if you do not know what data it was trained on, what population it was validated against, and how that population compares to yours.
Most health system AI governance policies start at tool deployment. The ones that actually work start here: with a requirement that any AI vendor disclose the demographic composition of their training data, the patient population against which performance was validated, and the clinical conditions under which the performance stats were generated.
This is not bureaucracy. This is how you find out whether the sepsis prediction tool with the impressive peer-reviewed accuracy was validated on patients who look nothing like yours.
The tool works in the lab. Does it work in your workflow?
This is the layer where the gap between vendor demo and clinical reality shows up. The AI-generated chest X-ray read is accurate: does the radiologist see it before or after rendering their own read? Does the system log when the AI recommendation was overridden? If so, why?
Clinical integration governance defines the specific interaction points between AI output and clinical decision-making. It names the feedback loops that tell you when the tool is behaving differently than expected. It specifies who has authority to pause or suspend the tool mid-deployment.
Most policies skip this layer. They describe what the AI can and cannot do. They do not describe how it interfaces with the human system around it.
The validation study that got this tool approved was done on historical data. Your patients are not historical data.
Real AI governance includes a performance monitoring protocol that tracks the tool's output against actual outcomes, flags distributional shifts (when the tool starts seeing patient populations significantly different from its training set), and has a defined threshold for triggering re-evaluation.
Without this layer, "the AI is performing well" means "the AI has not obviously failed in a way someone noticed."
When the algorithm influences a clinical decision that leads to harm, the accountability chain matters.
Who signed the contract with the vendor? What did the contract say about performance obligations? Who in the health system approved clinical deployment? Who had authority to override? Did they use it?
This is the layer boards should be asking about. The organizations that have thought through AI liability before they needed to are the ones that sleep better.
Layer 4 is not just legal protection. It is the organizational signal that someone has actually thought through what it means to make clinical decisions with algorithmic assistance.
The committee meets quarterly. The policy was last updated in 2023. The vendor released three product updates since then.
Layer 5 is the audit and update cycle: the defined cadence at which the governance stack itself is reviewed against the current state of the tools being governed. It is also the escalation path: the mechanism by which a frontline nurse who thinks something is wrong with the AI's recommendations can surface that concern to someone with authority to act.
Most governance documents do not have a layer 5. They have a "this policy will be reviewed annually" line at the bottom. That is not the same thing.
Organizations that have trouble scaling AI almost always have trouble at layer 1 or 2. They bought a tool that seemed well-validated, deployed it into a workflow that was not designed to absorb it, and then evaluated performance using metrics not connected to the problem they were trying to solve.
The 5-layer stack does not prevent that. It creates the conditions under which the organization can actually see it happening, with the authority structure to do something about it.
"A policy document tells you what you intend to govern. The stack is what you actually govern with."
I am a surgery-trained physician-executive currently practicing internal medicine (charity care), with experience building clinical AI governance frameworks during the Cerner acquisition at Oracle Health. I advise health systems on clinical AI strategy and implementation. For a 20-minute scoping conversation: calendly.com/sarahmattmd
If your governance stack stops at layer one, that is where the vendor exploits it. The Clinical AI Governance Audit maps all five layers against your current state in four weeks.